MicroRNA as Markers in Testicular Cancer

Recruiting Observational Study
Testicular Germ Cell Cancer Seminoma Non-Seminoma Testicular Cancer Stage I Testicular Cancer Stage II Testicular Cancer Stage III Testicular Cancer Stage IV Testicular Cancer Relapse Testicular Cancer
No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 70
Sex
Male
Study type
Observational
Participants needed
350 (estimated)
Sponsor
Haukeland University Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The main objective of this study is establish the performance of miR371 in management of testicular cancer

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Patients with suspected testicular cancer, referred to orchiectomy. * Patients diagnosed with testicular germ cell cancer. * Age 18-70 years of age. * Must be able receive information and to consent. Exclusion Criteria: * Other prior or concomitant malignancy (other than tes…
Contacts

Mette Pernille Myklebust, PhD

+47 41684492

mette.pernille.myklebust@helse-bergen.no

CONTACT

Olav Dahl, PhD

+47 55972081

olav.dahl@helse-bergen.no

CONTACT